In addition, clinical studies have revealed no difference in MCP-1 levels in patients with resistant vs. mild-to-moderate hypertension, but lower MCP-1 levels were recorded in hypertensive patients with LV hypertrophy (133). Here, CCL2 is linked to hypertensive disorder.